JG
Congress trade
Rep. Josh Gottheimer (D-NJ) bought $1K-$15K of Haemonetics Corporation (HAE) stock
Josh Gottheimer, U.S. Representative (D-NJ), disclosed a purchase of Haemonetics Corporation (HAE) stock worth $1K-$15K in a STOCK Act filing on Jun 10, 2020.
The trade happened on May 15, 2020, 26 days before it was made public.
HAE has moved +4.3% since the trade date, from $100.37 to $104.68 (Oct 2, 2026 close).
- Traded
- May 15, 2020
- Disclosed
- Jun 10, 2020
- Filing delay
- 26 days
- Price since
- +4.3%
- Source
- STOCK Act disclosure
Other trades in this disclosure (32)
- SellAMZN$50K-$100KJun 10, 2020
- SellAAPL$15K-$50KJun 10, 2020
- SellBX$15K-$50KJun 10, 2020
- SellGS$15K-$50KJun 10, 2020
- SellJPM$15K-$50KJun 10, 2020
- SellMSFT$15K-$50KJun 10, 2020
- SellAMD$1K-$15KJun 10, 2020
- SellAMGN$1K-$15KJun 10, 2020
- SellCENT$1K-$15KJun 10, 2020
- SellCMD$1K-$15KJun 10, 2020
- SellCNI$1K-$15KJun 10, 2020
- SellCTLT$1K-$15KJun 10, 2020
- SellCTLT$1K-$15KJun 10, 2020
- BuyCVX$1K-$15KJun 10, 2020
- SellDAL$1K-$15KJun 10, 2020
- SellDXCM$1K-$15KJun 10, 2020
- SellFIS$1K-$15KJun 10, 2020
- SellGMED$1K-$15KJun 10, 2020
- SellGOOG$1K-$15KJun 10, 2020
- BuyGRUB$1K-$15KJun 10, 2020
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.